Sutro Biopharma, Inc. STRO
$25.38
+5.09%
at last close
Financials (TTM)
- Revenue
- $99.61 million
- Net Income
- $-153,602,000
- Net Margin
- -154.21%
- Return on Equity
- 229.64%
- Debt-to-Equity
- —
- P/E Ratio
- —
- Price / Book
- -6.29
- Price / Sales
- 4.22
Over the trailing twelve months, Sutro Biopharma, Inc. generated revenue of $99.61 million and net income of $-153,602,000, a net margin of -154.21%.
At the last closing price of $25.38, STRO trades at 4.22 times sales, with a market capitalization of $420.56 million.
Key Stats
- Last Close
- $25.38
- Market Cap
- $420.56 million
- 52-Week Range
- $7.15 – $43.85
- Average Volume
- 383K shs
Data is delayed and provided for informational purposes only. Not investment advice. See our disclaimer.